on 19 Dec 2024
Last Applicant/ Owned by
Suzanne Tassierstraat 1
Gent
BE
9052
Serial Number
97701222 filed on 02th Dec 2022
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Science and technology services, namely, scientific and technological research in the field of pharmaceuticals, medical science, and veterinary science; Natural science services, namely, scientific research; Scientific research, namely, medical, bacteriological, chemical, bio-technical and pharmacological research services; Clinical research, namely, scientific research in the nature of conducting Read More
Science and technology services, namely, scientific and technological research in the field of pharmaceuticals, medical science, and veterinary science; Natural science services, namely, scientific research; Scientific research, namely, medical, bacteriological, chemical, bio-technical and pharmacological research services; Clinical research, namely, scientific research in the nature of conducting clinical trials for others; medical laboratory services; conducting early evaluations in the field of new pharmaceuticals; Consultancy relating to pharmaceutical research and development; Drug discovery services; all of the aforesaid services not relating to means for pest control, fungicides, germicides and herbicide, and not relating to means for diagnostics
N/A
N/A
Pharmaceutical preparations and substances, namely, biotherapeutics for targeted protein degradation in cancer, immunological disease, and autoimmunological disease; Medical preparations and substances, namely, liquid, solid, and lyophilized protein-based preparations for medical uses and treatments for cancer, immunological disease, and autoimmunological disease; Medical and veterinary preparations and substances in the nature of liquid, solid, and lyophilized protein-based biotherapeutic preparations for the treatment, mitigation, diagnosis, or prevention of diseases, conditions, and symptoms related to metabolism, allergies, immune and inflammatory diseases, infectious diseases, the cardiovascular system, the pulmonary system, the respiratory system, oncology, dermatology, the gastrointestinal system, topical illnesses, neurology, endocrinology, the urological system, the reproductive system, nutritional needs, ophthalmic system, renal system, blood and blood-related disorders, integumentary and lymphatic systems in humans and animals; Veterinary preparations in the nature of medication for use in the treatment, mitigation, diagnosis, or prevention of diseases, conditions, and symptoms related to metabolism, allergies, immune and inflammatory diseases, infectious diseases, the cardiovascular system, the pulmonary system, the respiratory system, oncology, dermatology, the gastrointestinal system, topical illnesses, neurology, endocrinology, the urological system, the reproductive system, nutritional needs, ophthalmic system, renal system, blood and blood-related disorders, integumentary and lymphatic systems in humans and animals; therapeutic preparations for pharmaceutical, medical and veterinary purposes, namely, pharmaceutical preparations for the treatment of disease, namely, cancer, immunological disorders, and autoimmunological disorders in humans and animals; bioculture preparations for pharmaceutical, medical, and veterinary purposes, namely, cultures of microorganisms for medical or veterinary use; Preparations and substances for use in drug discovery, namely, clinical medical reagents; all of the aforesaid goods excluding means for pest control, fungicides, germicides and herbicides and excluding means for diagnostics
N/A
N/A
No 97701222
No Service Mark
No HDCPA-T466US
Yes
Yes
Yes
Yes
No
No
No
No
Status Date | Action Taken |
---|---|
19th Dec 2024 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
13th Dec 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
30th Aug 2024 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
30th Aug 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
30th Aug 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
30th Aug 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
30th Aug 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
31st May 2024 | FINAL REFUSAL WRITTEN |
31st May 2024 | FINAL REFUSAL E-MAILED |
31st May 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |